Diabetes | Hypertension | Cardiovascular disease | Musculoskeletal disease | ||||||
---|---|---|---|---|---|---|---|---|---|
Baseline prevalence (%) [95% CI] | 5.3 [4.7;6.0] | 29.0 [27.5;30.5] | 6.8 [6.4;7.2] | 35.5 [34.8;36.2] | |||||
OR (BMI) [95% CI] (for 1 IQR increase) | 1.6 [1.4;1.8] | 1.9 [1.6;2.1] | 1.1 [1.0;1.2] | 1.2 [1.1;1.3] | |||||
OR (WC) [95% CI] (for 1 IQR increase) | 1.9 [1.6;2.4] | 2.0 [1.7;2.4] | 1.2 [1.0;1.4] | 1.2 [1.1;1.3] | |||||
Target pop | BMI > 25 | BMI > 30 | BMI > 25 | BMI > 30 | BMI > 25 | BMI > 30 | BMI > 25 | BMI > 30 | |
(1) | RD (%) [95% CI] | -1.7 [-2.1;-1.3] | -1.2 [-1.5;-0.9] | -6.8 [-8.1;-5.6] | -4.4 [-5.2;-3.6] | -0.6 [-1.1;-0.2] | -0.4 [-0.7;-0.1] | -2.1 [-3.0;-1.3] | -1.3 [-1.9;-0.8] |
PIF (%) [95% CI] | 32.3 [25.2;39.3] | 22.9 [17.4;28.4] | 23.3 [9;27.6] | 15 [12.1;17.9] | 9 [2.4;15.5] | 5.9 [1.5;10.4] | 6 [3.6;8.5] | 3.8 [2.2;5.3] | |
(2) | RD (%) [95% CI] | -0.3 [-0.5;-0.1] | -0.1 [-0.2;-0.1] | -0.8 [-1.3;-0.4] | -0.4 [-0.4;-0.3] | -0.1 [-0.2;-0.0] | -0.04 [-0.1;0.0] | -0.3 [-0.4;-0.2] | -0.1 [-0.2;-0.1] |
PIF (%) [95% CI] | 4.5 [3.4;5.7] | 2.4 [1.7;3.1] | 3.3 [2.2;4.3] | 1.3 [0.8;1.8] | 1.5 [0.9;3.8] | 0.5 [0.1;0.9] | 0.8 [0.5;1.1] | 0.3 [0.2;0.4] | |
(3) | RD (%) [95% CI] | -0.7 [-0.9;-0.5] | -0.4 [-0.6;-0.3] | -2.7 [-3.2;-2.1] | -1.3 [-1.5;-1.0] | -0.2 [-0.4;-0.1] | -0.1 [-0.2;-0.0] | -0.8 [-1.2;-0.5] | -0.4 [-0.5;-0.2] |
PIF (%) [95% CI] | 13.6 [10.3;16.9] | 8.0 [5.8;10.3] | 9.2 [7.3;11] | 4.4 [3.5; 5.3] | 3.5 [-0.9;6.1] | 1.8 [0.4;3.1] | 2.4 [1.4;3.3] | 1.1 [0.6;1.6] | |
Target pop | WC:height ratio > 0.5 | ||||||||
(4) | RD (%) [95% CI] | -2.1 [-3.1;-1] | -7.2 [-8.6;-6] | -0.7 [-1.3;-0.2] | -2.5 [-3.3;-1.7] | ||||
PIF (%) [95% CI] | 36.4 [27.5;47.3] | 24.7 [20.6;28.9] | 10.8 [3.3;18.3] | 7.1 [4.7;9.4] |